UB Paderborn / Katalog / Suche / in CDI

Effect of canagliflozin on circulating active GLP-1 levels in patients with type 2 diabetes: a randomized trial

Endocrine Journal, 2017, Vol.64(9), pp.923-931

2017

Volltextzugriff (PDF)

Effect of canagliflozin on circulating active GLP-1 levels in patients with type 2 diabetes : a randomized trial

ENDOCRINE JOURNAL, 2017-09, Vol.64 (9), p.923-931

2017

Volltextzugriff (PDF)

Effect of combination therapy with alogliptin and lansoprazole on glycemic control in patients with type 2 diabetes

Endocrine Journal, 2014, Vol.61(10), pp.1031-1039

2014

Volltextzugriff (PDF)

Effect of combination therapy with alogliptin and lansoprazole on glycemic control in patients with type 2 diabetes

ENDOCRINE JOURNAL, 2014-10, Vol.61 (10), p.1031-1039

2014

Volltextzugriff (PDF)

Retinol Binding Protein-4 Levels and Clinical Features of Type 2 Diabetes Patients

The journal of clinical endocrinology and metabolism, 2007-07, Vol.92 (7), p.2712-2719

2007

Volltextzugriff (PDF)

Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus

Metabolism, clinical and experimental, 2007-04, Vol.56 (4), p.451-458

2007

Volltextzugriff (PDF)

Improvement of Vascular Endothelial Function at an Early Stage by the Original Stretching Exercise Designed in Our Study Group in Patients with Type 2 Diabetes Mellitus

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea

Translational research : the journal of laboratory and clinical medicine, 2012, Vol.159 (1), p.25-31

2012

Volltextzugriff (PDF)

Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetes

Diabetes research and clinical practice, 2010-12, Vol.90 (3), p.250-255

2010

Volltextzugriff (PDF)

Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia

Southern medical journal (Birmingham, Ala.), 2009-04, Vol.102 (4), p.361

2009

Volltextzugriff (PDF)

Oxidative stress and antioxidative potency are closely associated with diabetic retinopathy and nephropathy in patients with type 2 diabetes

Saudi medical journal, 2013-02, Vol.34 (2), p.135

2013

Volltextzugriff (PDF)

Circulating SerpinB1 levels and clinical features in patients with type 2 diabetes

BMJ open diabetes research & care, 2016-01, Vol.4 (1), p.e000274-e000274

2016

Volltextzugriff (PDF)

Long-Term Effect of Alogliptin on Glycemic Control in Japanese Patients With Type 2 Diabetes: A 3.5-Year Observational Study

Journal of clinical medicine research, 2017-09, Vol.9 (9), p.802-808

2017

Volltextzugriff (PDF)

Serum Betatrophin Levels and Clinical Features in Patients With Poorly Controlled Type 2 Diabetes

Journal of clinical medicine research, 2017-09, Vol.9 (9), p.782-787

2017

Volltextzugriff (PDF)

Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes

Diabetes research and clinical practice, 2009-08, Vol.85 (2), p.147-152

2009

Volltextzugriff (PDF)

Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction

Translational research : the journal of laboratory and clinical medicine, 2009-10, Vol.154 (4), p.175-182

2009

Volltextzugriff (PDF)

Serum high–molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus

Metabolism, clinical and experimental, 2009-10, Vol.58 (10), p.1470-1476

2009

Volltextzugriff (PDF)

Alterations of plant sterols, lathosterol, oxidative stress and inflammatory markers after the combination therapy of ezetimibe and statin drugs in type 2 diabetic patients

Obesity research & clinical practice, 2015-01, Vol.9 (1), p.67-74

2015

Volltextzugriff (PDF)

Correlation of high-sensitivity C-reactive protein and plasma fibrinogen with individual complications in patients with type 2 diabetes

Southern medical journal (Birmingham, Ala.), 2006-01, Vol.99 (1), p.23

2006

Volltextzugriff (PDF)

Relationships between Heart Rate Variability and Urinary Albumin Excretion in Patients with Type 2 Diabetes

The American journal of the medical sciences, 2006-02, Vol.331 (2), p.72-78

2006

Volltextzugriff (PDF)

Increase in average foveal thickness after internal limiting membrane peeling

Clinical ophthalmology (Auckland, N.Z.), 2017-01, Vol.11, p.605-611

2017

Volltextzugriff (PDF)

CENTRIPETAL MOVEMENT OF THE CAPILLARIES IN THE CENTRAL MACULAR REGION AFTER INTERNAL LIMITING MEMBRANE PEELING

Retinal cases & brief reports, 2019, Vol.13 (1), p.39

2019

Volltextzugriff (PDF)

Effect of vitreomacular adhesion and vitreous gel on age-related reduction of macular thickness: a retrospective observational study

BMJ open, 2016-09, Vol.6 (9), p.e012972-e012972

2016

Volltextzugriff (PDF)

Increase in average foveal thickness after internal limiting membrane peeling

Clinical ophthalmology (Auckland, N.Z.), 2017-01, Vol.11, p.605

2017

Volltextzugriff (PDF)

Decrease of the foveal avascular zone area after internal limiting membrane peeling: single case study

International medical case reports journal, 2017-01, Vol.10, p.81-85

2017

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Effect of canagliflozin on circulating active GLP-1 levels in patients with type 2 diabetes: a randomized trial

Effect of canagliflozin on circulating active GLP-1 levels in patients with type 2 diabetes : a randomized trial

Effect of combination therapy with alogliptin and lansoprazole on glycemic control in patients with type 2 diabetes

Effect of combination therapy with alogliptin and lansoprazole on glycemic control in patients with type 2 diabetes

Retinol Binding Protein-4 Levels and Clinical Features of Type 2 Diabetes Patients

Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus

Improvement of Vascular Endothelial Function at an Early Stage by the Original Stretching Exercise Designed in Our Study Group in Patients with Type 2 Diabetes Mellitus

Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea

Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetes

Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia

Oxidative stress and antioxidative potency are closely associated with diabetic retinopathy and nephropathy in patients with type 2 diabetes

Circulating SerpinB1 levels and clinical features in patients with type 2 diabetes

Long-Term Effect of Alogliptin on Glycemic Control in Japanese Patients With Type 2 Diabetes: A 3.5-Year Observational Study

Serum Betatrophin Levels and Clinical Features in Patients With Poorly Controlled Type 2 Diabetes

Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes

Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction

Serum high–molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus

Alterations of plant sterols, lathosterol, oxidative stress and inflammatory markers after the combination therapy of ezetimibe and statin drugs in type 2 diabetic patients

Correlation of high-sensitivity C-reactive protein and plasma fibrinogen with individual complications in patients with type 2 diabetes

Relationships between Heart Rate Variability and Urinary Albumin Excretion in Patients with Type 2 Diabetes

Increase in average foveal thickness after internal limiting membrane peeling

CENTRIPETAL MOVEMENT OF THE CAPILLARIES IN THE CENTRAL MACULAR REGION AFTER INTERNAL LIMITING MEMBRANE PEELING

Effect of vitreomacular adhesion and vitreous gel on age-related reduction of macular thickness: a retrospective observational study

Increase in average foveal thickness after internal limiting membrane peeling

Decrease of the foveal avascular zone area after internal limiting membrane peeling: single case study

Suchergebnisse filtern